Folate hydrolase‐1 (FOLH1) is a novel target for antibody‐based brachytherapy in Merkel cell carcinoma
Abstract Backgrounds Folate Hydrolase‐1 (FOLH1; PSMA) is a type II transmembrane protein, luminally expressed by solid tumour neo‐vasculature. Monoclonal antibody (mAb), J591, is a vehicle for mAb‐based brachytherapy in FOLH1+ cancers. Brachytherapy is a form of radiotherapy that involves placing a...
Saved in:
Main Authors: | M. K. Ramirez‐Fort (Author), B. Meier‐Schiesser (Author), K. Lachance (Author), S. S. Mahase (Author), C. D. Church (Author), M. J. Niaz (Author), H. Liu (Author), V. Navarro (Author), A. Nikolopoulou (Author), D. V. Kazakov (Author), E. Contassot (Author), D. P. Nguyen (Author), J. Sach (Author), L. Hadravsky (Author), Y. Sheng (Author), S. T. Tagawa (Author), X. Wu (Author), C. S. Lange (Author), L. E. French (Author), P. T. Nghiem (Author), N. H. Bander (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Brachytherapy
Published: (2012) -
Hydrolases
Published: (2022) -
Immune checkpoint inhibitor therapy in HIV-associated Merkel cell carcinoma: A case series of 3 patients
by: Song Y. Park, MD, et al.
Published: (2021) -
Editorial: Clinical Paths for Soluble Epoxide Hydrolase Inhibitors
by: John D. Imig, et al.
Published: (2020) -
High-dose rate brachytherapy in the treatment of cancer of the cervix uteri
by: D. A. Aliyev, et al.
Published: (2014)